myNEO Company

myNEO engages in the research, development, and optimization of the clinical exploitability of personalized cancer immunotherapy.

Industry: Preclinical Development
Founded Date: 2018-01-01
Headquarters: Ghent, Oost-Vlaanderen, Belgium